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Abstract 
BACKGROUND: Uncaria gambir (local name: gambir) is a plant native to Sumatera, Malaya and Borneo. This 
plant is potential as local wisdom for therapeutics. In Sumatera, gambir was used as a traditional treatment for 
fever, diarrhoea, diabetics and wound healing. 
AIM: To explore the efficacy of gambir extract on TNF alpha level, prostaglandin E2 level, lesson area, body 
weight, lipid profile and leptin level in Wistar rat-model gastritis. 
METHODS: This study was an experimental study, with a pre-post-test control group design. The subjects in this 
study were 30 male rats, 8 weeks old, weight 150-200 gram. Rats were administered with gambir extract at the 
dose of 20, 40 and 80 mg/kg BW/day for 3 days. Gambir was extracted by maceration methods. Statistical 
analysis was performed by SPSS 18. 
RESULTS: Gambir extract at the dose of 80 mg/kg BW exhibited the highest efficacy in reducing TNF alpha level, 
lesion area and increasing prostaglandin E2 level compared to gambir extract at doses of 20 mg/kg BW, 400 
mg/kg BW, negative control, and positive control. 
CONCLUSION: Gambir extract was effective in reducing TNF alpha level, lesson area, and increasing 
prostaglandin E2 level in Wistar rat-model gastritis. 
 
 
 
 
 
 
 
 
Introduction 
 
Gastritis is an inflammatory condition that 
occurs in the gastric mucosa. The symptoms resulting 
from gastric mucosa inflammation are burning 
sensation and discomfort in the stomach. Gastritis is 
one of the serious health problems in the world [1]. 
The incidence of chronic gastritis increases with age. 
In Western countries, the prevalence of gastritis 
sufferers is almost 80% in the elderly population of 
sixty years old and predicted to become 100% in the 
population of seventy years old. Chemical irritants of 
gastric mucosae, such as alcohol and aspirin, induce 
chemical injury in gastric mucosa. It is one of the 
serious exogenous factors that induces gastric 
mucosa inflammation that will lead to gastritis [2]. Anti-
gastritis drugs, such as antacids, PPI or H2 
antagonists, are oral medications commonly used in 
the management of gastritis. The undesirable side 
effects of using oral anti-gastritis drugs are 
considerable, therefore exploring new drug 
compounds from natural ingredients is expected to be 
a solution to the discovery and development of new 
drugs with better efficacy and safety [3], [4], [5]. 
Indonesia is one of the countries with a rich 
Basic Science 
_______________________________________________________________________________________________________________________________ 
 
_______________________________________________________________________________________________________________________________ 
3150                                                                                                                                                                                              https://www.id-press.eu/mjms/index 
 
biodiversity of medicinal plants. Gambir (Uncaria 
gambir) from the Rubiaceae family is one of Indonesia 
native medicinal plants [6]. Wide varieties of the study 
had been conducted to explore the potential effect of 
Gambir [7], [8], [9]. This study aimed to assess the 
potential of gambir extract in treating gastritis in vivo, 
which would further explore the effect of extracts on 
TNF-α and prostaglandin E2 so that new standardised 
herbs could be obtained in the management of 
gastritis. 
 
 
Material and Methods 
 
The study design was an experimental study, 
with post-test control group design. The study had 
been approved by the Bioethics Committee, Faculty of 
Medicine, Universitas Sriwijaya (189/kpt-
fkunsri/rsmh/2017). 
Gambir were provided by Indonesia 
Traditional Herbal Research Center, Tawangmangu, 
Central Java, Indonesia. Gambir was washed, dried 
and drilled, followed by maceration method by ethanol 
96%, evaporated and gambir extract was obtained. 
Phytochemical analysis through Thin Layer 
Chromatography (TLC) was performed to obtain the 
component information of gambir extract. 
Thirty rats (Eureka Research Laboratory, 
Indonesia) were used in this study. Inclusion criteria 
were male Wistar rats, eight weeks old, weight 150-
200 gram and healthy. Rats were divided into 5 
groups; every group consisted of 6 rats. Gastritis in 
rats was induced by administrating ethanol 96% for 3 
days. Rats were treated, group 1: aqua dest 1 mL 
(negative control), group 2: ranitidine 20 mg/kg BW 
(positive control), group 3: gambir extract 20 mg/kg 
BW, group 4: gambir extract 40 mg/kg BW, and group 
5: gambir extract 80 mg/kg BW. Treatment was 
carried out for 3 days. 
Following the performed treatments, rats were 
killed by anaesthesia. Rats gastric organ was 
evacuated, washed and assayed for lesion area size 
by callipers, and the tissue was obtained for 
homogenisation by centrifugation 3000 rpm, at -4°C, 
for 20 minutes. The supernatant was collected and 
used to assay TNF alpha and prostaglandin E2 level 
using ELISA methods. The procedure of ELISA was 
based on the assay protocol on the manual (Cloud-
Clone Corp®, Texas, USA). The sample solution was 
bottled using the capillary tube on Silica GF silent 
phase 254 which was activated by heating at 105°C-
110°C for 1 hour then eluted with methanol: 
chloroform phase (1: 39) v/v. Chromatogram results 
were observed in UV254 nm. Spotting was detected 
by H2SO4 spray. 
The statistical analysis was done by SPSS 
18.0 (SPSS Inc., Chicago, Illinois, USA). Data were 
assessed for bivariate and multivariate analysis. T-test 
was used for bivariate analysis and pos hoc test for 
multivariate analysis. 
 
 
Results 
 
As shown in Table 1, gambir extract at the 
dose of 80 mg/kg BW was the most effective in 
reducing lesion area size, TNF alpha level and 
increasing prostaglandin E2 level compared to gambir 
extract at the dose of 20 mg/kg BW, 40 mg/kg BW, 
negative control and positive control. Gambir extract 
showed dose-dependent manner efficacy in reducing 
lesion area size, TNF alpha level and increasing 
prostaglandin E2 level. Gambir extracts at the dose of 
80 mg/kg BW possesses higher efficacy to reduce 
lesion area size, TNF alpha level and increase 
prostaglandin E2 level compared to gambir extract at 
doses of 20 mg/kg BW and 40 mg/kg BW. The 
increasing doses of the extract were positively related 
to the efficacy to reduce lesion area size, TNF alpha 
level and increase prostaglandin E2 level, thus 
affecting the gastric mucosal lesion. 
Table 1: The Efficacy of Gambir Extract on Lesion Area, TNF 
Alpha and Prostaglandin E2 
Variable Group Mean ± SD p-value
*
 
Lession area (mm) Negative control 
Positive control 
Extract 20 mg/kg BW 
Extract 40 mg/kg BW 
Extract 80 mg/kg BW 
2.72 ± 0,83 
0.42 ± 0,13 
0.58 ± 0.22 
0.43 ± 0.24 
0.29 ± 0.10 
0.01 
- 
0.01 
0.56 
0.02 
TNF alpha (pg/mL) Negative control 
Positive control 
Extract 50 mg/kg BW 
Extract 100 mg/kg BW 
Extract 200 mg/kg BW 
212 ± 10.09 
170 ± 13,76 
198 ± 20.53 
169 ± 10.78 
149 ± 10.84 
0.01 
- 
0.01 
0.43 
0.01 
Prostaglandin E2 (pg/mL) Negative control 
Positive control 
Extract 50 mg/kg BW 
Extract 100 mg/kg BW 
Extract 200 mg/kg BW 
28.78 ± 7.87 
60,65 ± 11.09 
49.23 ± 7.34 
61.23 ± 5.87 
73.13 ± 6.35 
0.01 
- 
0.01 
0.34 
0.02 
*Paired T test; VS positive control; p = 0.05. 
 
Phytochemical Analysis 
Qualitative test of phytochemical component 
performed on gambir extract exhibited that gambir 
contained an alkaloid, steroid/ternoid (essential oil), 
and flavonoid components. 
 
Figure 1: Thin Layer Chromatography Analysis of Gambir Extract 
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Discussion 
 
Gambir extract showed dose-dependent 
manner efficacy in reducing lesion area size, TNF 
alpha level and increasing prostaglandin E2 level. 
Gambir extracts at the dose of 80 mg/kg BW 
possesses higher efficacy to reduce lesion area size, 
TNF alpha level and increase prostaglandin E2 level 
compared to gambir extract at doses of 20 mg/kg BW 
and 40 mg/kg BW. The increasing doses of the extract 
were positively related to the efficacy to reduce lesion 
area size, TNF alpha level and increase prostaglandin 
E2 level, thus affecting the gastric mucosal lesion in 
rats [10], [11]. Based on the phytochemical analysis, 
gambir extract contained an alkaloid, steroid and 
flavonoid. Quercetin (one of flavonoid) 
supplementation was reported to reduce stress 
oxidative in hypertensive patients [12]. Its antioxidant 
activity may also suppress the elevation of oxidant, 
MDA in diet-induced obesity rat models [13], [14]. 
Quercetin was reported to downregulate the 
expression of NfKB, TNF alpha and other 
proinflammatory cytokines. Flavonoid had the 
potential to reduce the damaged of the gastric 
mucosal membrane by inhibiting apoptosis and 
reducing anti-inflammatory activity. Flavonoid had the 
efficacy to inhibit apoptosis in 3T3-L1 preadipocytes 
by decreasing the mitochondria membrane potential, 
downregulating expression of B-cell lymphoma 2 (Bcl-
2) and poly (ADP-ribose) polymerase (PARP), and 
activating Bcl-2 homologous antagonist/killer (Bak), 
Bcl-2-associated X protein (Bax), and cysteine-
dependent aspartate-directed proteases 3 (caspase 3) 
[15], [16]. Gambir extract was the potential to inhibit 
inflammation in the gastric mucosal membrane by 
decreasing the inflammatory process through 
increased prostaglandin E2. Prostaglandin E2 plays a 
pivotal role to protect gastric mucosal membrane [17]. 
Prostaglandin E2 is a prostaglandin with 
complex biological activity, which is involved in GI-RI 
inflammation [18]. PGE2 synthase is the last key 
enzyme in the synthesis of prostaglandin E2. 
Prostaglandin E2 is the prostaglandin with the highest 
abundance and greatest distribution in the human 
body. It serves a major role in inflammation as a pain 
and fever mediator during inflammation. Additionally, it 
may induce vasodilation and microvascular leakage 
[19]. As a type of unsaturated fatty acid, prostaglandin 
E2 is predominantly composed of 20 carbon atoms. It 
has the basic structure of one five-carbon ring and two 
side chains. Arachidonic acid is synthesised into 
prostaglandin E2 under the catalysis of 
cyclooxygenase (COX) and prostaglandin synthase 
[20]. Prostaglandin E2 escapes through facilitated 
diffusion and binds to E-prostanoid 1 – 4 in an 
autocrine or paracrine manner. In this way, it may 
alter the levels of intracellular second messengers, 
and send signals to cells, causing a series of 
physiological or pathophysiological changes [18]. 
Cyclooxygenase prevents the conversion of 
arachidonic acid into prostaglandin E2. Therefore, it 
may quickly alleviate active substance-induced 
inflammation. As a result, it may reduce the excitability 
of the peripheral and central pain-sensing conduction 
system [21]. Thus, COX-2 serves anti-inflammatory 
and analgesic functions. Prostaglandins may promote 
the secretion of gastric fluid and bicarbonate. In this 
manner, they can protect the gastric mucosal barrier, 
promote the renewal of gastric mucosal cells and 
improve mucosal blood flow. Furthermore, COX-2 
may stimulate the active transport process of cells, 
activate adenylate cyclase and stabilise the lysosome. 
It may also maintain the level of mucosal thiol 
compounds and stimulate surface-active 
phospholipids in gastric mucosa [22]. 
TNF-α, the major pro-inflammatory cytokine 
released from the migrated macrophages, plays an 
important role in the pathogenesis of gastric ulcers 
through stimulation of intercellular adhesion molecule 
(ICAM)-1 expression on vascular endothelial cells 
which increases leukocyte adhesion to the endothelial 
surface on post-capillary venules and promotes 
transendothelial migration of leukocytes to 
inflammatory sites [23]. TNF-α also increases 
intracellular oxidative stress and up-regulation of 
cytokine-induced neutrophil chemoattractant (CINC)-1 
mRNA and protein in gastric epithelial cells [24]. 
In conclusion, the gambir extract exhibited 
efficacy in increasing gastric mucosal integrity through 
reducing lesion area size, TNF alpha level and 
increasing prostaglandin E2 level. 
 
 
References 
 
1. Kumar V, Abbas AK, Fausto N, Aster JC. Robbins and Cotran 
Pathologic Basis of Disease. 8th edition. Saunders Elsevier, 
Philadelphia, USA, 2011. 
2. Liu X, Chen Z, Mao N, Xie Y. The protective of hydrogen on 
stress-induced gastric ulceration. Int Immunopharmacol. 2012; 
13(2):197-203. https://doi.org/10.1016/j.intimp.2012.04.004 
PMid:22543062 
 
3. Choi JI, Raghavendran HRB, Sung N, Kim JH, Chun BS, Ahn 
DH, et al. Effect of nigella sativa on aspirin-induced stomach 
ulceration in rats. Chemico-Biological Interactions. 2010; 
183(1):249-54. https://doi.org/10.1016/j.cbi.2009.09.015 
PMid:19788892 
 
4. Thong-Ngam D, Choochuay S, Patumraj S, Chayanupatkul M, 
Klaikaew N. Curcumin prevents indomethacin-induced gastropathy 
in rats. World J Gastroenterol. 2012; 18(13):1479-84. 
https://doi.org/10.3748/wjg.v18.i13.1479 PMid:22509079 
PMCid:PMC3319943 
 
5. Kumar A, Chomwal R, Kumar P, Sawal R. Anti-inflammatory and 
wound healing activity of Curcuma aromatica salisb extract and its 
formulation. J Chem Pharm Res. 2009; 1(1):304-10. 
 
6. Hussin MH, Kassim MJ. The corrosion inhibition and adsorption 
behavior of Uncaria gambir extract on mild steel in 1 M HCl. Mater 
Chem Phys. 2011; 125(3):461-8. 
https://doi.org/10.1016/j.matchemphys.2010.10.032 
 
Basic Science 
_______________________________________________________________________________________________________________________________ 
 
_______________________________________________________________________________________________________________________________ 
3152                                                                                                                                                                                              https://www.id-press.eu/mjms/index 
 
7. Amir M, Mujeeb M, Khan A, Ashraf K, Sharma D, Aqil M. 
Phytochemical analysis and in vitro antioxidant activity of Uncaria 
gambir. Int J Green Pharm. 2012 ;6(1):67-72. 
https://doi.org/10.4103/0973-8258.97136 
 
8. Anggraini T, Akihiro T, Yoshino T, Itani T. Antioxidative activity 
and catechin content of four kinds of Uncaria gambir extracts from 
West Sumatra Indonesia. Afr J Biochem Res. 2011; 5(1):33-8. 
 
9. Widiyarti G, Sundowo A, Hanafi M. The free radical scavenging 
and anti-hyperglycemic activities of various gambirs available in 
Indonesian market. Makara Sains. 2011; 15(2):129-34. 
https://doi.org/10.7454/mss.v15i2.1062 
 
10. Yoshikawa T, Naito Y, Ueda S, Oyamada H, Takemura T, 
Yoshida N, Sugino S, Kondo M. Role of oxygen-derived free 
radicals in the pathogenesis of gastric mucosal lesions in rats. J 
Clin Gastroenterol. 1990; 12(1):S65-71. 
https://doi.org/10.1097/00004836-199001001-00012 
PMid:2212551 
 
11. Naito Y, Yoshikawa T, Matsuyama K, Yagi N, Arai M, 
Nakamura Y, et al. Effects of oxygen radical scavengers on the 
quality of gastric ulcer healing in rats. J Clin Gastroenterol. 1995; 
21(1):S82-6. 
 
12. Eseberri I, Miranda J, Lasa A, Churruca I, Portillo MP. Doses of 
quercetin in the range of serum concentrations exert delipidating 
effects in 3T3-L1 preadipocytes by acting on different stages of 
adipogenesis, but not in mature adipocytes. Oxid Med Cell Longev. 
2015; 2015:480943. https://doi.org/10.1155/2015/480943 
PMid:26180590 PMCid:PMC4477249 
 
13. Kleemann R, Verschuren L, Morrison M, Zadelaar S, van Erk 
M, Wielinga PY, et al. Anti-inflammatory, anti-proliferative and anti-
atherosclerotic effects of quercetin in human in vitro and in vivo 
models. Atherosclerosis. 2011; 218(1):44-52. 
https://doi.org/10.1016/j.atherosclerosis.2011.04.023 
PMid:21601209 
 
14. Yang JY, Della-Fera MA, Rayalam S, Ambati S, Hartzell DL, 
Park HJ, et al. Enhanced inhibition of adipogenesis and induction 
of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol 
and quercetin. Life Sci. 2008; 82:1032-9. 
https://doi.org/10.1016/j.lfs.2008.03.003 PMid:18433793 
 
15. Hsu CL, Yen GC. Induction of cell apoptosis in 3T3-L1 pre-
adipocytes by flavonoids is associated with their antioxidant 
activity. Mol Nutr Food Res. 2006; 50:1072-9. 
https://doi.org/10.1002/mnfr.200600040 PMid:17039455 
 
16. Yamamoto Y, Oue E. Antihypertensive effect of quercetin in 
rats fed with a high-fat high-sucrose diet. Biosci Biotechnol 
Biochem. 2006; 70(4):933-9. https://doi.org/10.1271/bbb.70.933 
PMid:16636461 
 
17. Villegas I, La Casa C, de La Lastra CA, Motilva V, Herrer'ıas 
JM, Mart'ın MJ. Mucosal damage induced by preferential COX-1  
and COX-2 inhibitors: role of prostaglandins and inflammatory 
response. Life Sci. 2004; 74(7):873-84. 
https://doi.org/10.1016/j.lfs.2003.07.021 PMid:14659976 
18. Del Carmen S, de Moreno de, LeBlanc A, LeBlanc JG. 
Development of a potential probiotic yoghurt using selected anti-
inflammatory lactic acid bacteria for prevention of colitis and 
carcinogenesis in mice. J Appl Microbiol. 2016; 121:821-830. 
https://doi.org/10.1111/jam.13213 PMid:27341191 
 
19. Negroni A, Prete E, Vitali R, Cesi V, Aloi M, Civitelli F, 
Cucchiara S, Stronati L. Endoplasmic reticulum stress and 
unfolded protein response are involved in paediatric inflammatory 
bowel disease. Dig Liver Dis. 2014; 46:788-794. 
https://doi.org/10.1016/j.dld.2014.05.013 PMid:24953208 
 
20. Roblin X, Boschetti G, Williet N, Nancey S, Marotte H, Berger 
A, Phelip JM, Peyrin-Biroulet L, Colombel JF, Del Tedesco E. 
Azathioprine dose reduction in inflammatory bowel disease 
patients on combination therapy: An open-label, prospective and 
randomised clinical trial. Aliment Pharmacol Ther. 2017; 46:142-
149. https://doi.org/10.1111/apt.14106 PMid:28449228 
 
21. Brzozowski T, Konturek PC, Konturek SJ, Sliwowski Z, 
Drozdowicz D, Stachura J, Pajdo R, Hahn EG. Role of 
prostaglandins generated by cyclooxygenase-1 and 
cyclooxygenase-2 in healing of ischemia-reperfusion-induced 
gastric lesions. Eur J Pharmacol. 1999; 385:47-61. 
https://doi.org/10.1016/S0014-2999(99)00681-0 
 
22. Tlaskalová-Hogenová H, Stěpánková R, Kozáková H, Hudcovic 
T, Vannucci L, Tučková L, Rossmann P, Hrnčíř T, Kverka M, 
Zákostelská Z, et al. The role of gut microbiota (commensal 
bacteria) and the mucosal barrier in the pathogenesis of 
inflammatory and autoimmune diseases and cancer: Contribution 
of germ-free and gnotobiotic animal models of human diseases. 
Cell Mol Immunol. 2011; 8:110-120. 
https://doi.org/10.1038/cmi.2010.67 PMid:21278760 
PMCid:PMC4003137 
 
23. Kast RE. Tumor necrosis factor has positive and negative self 
regulatory feed back cycles centered around cAMP. Int J 
Immunopharmacol. 2000; 22(11):1001-1006. 
https://doi.org/10.1016/S0192-0561(00)00046-1 
 
24. Konturek PC, Duda A, Brzozowski T, Konturek SJ, Kwiecien S, 
Drozdowicz D, et al Activation of genes for superoxide dismutase, 
interleukin-1beta, tumor necrosis factor-alpha, and intercellular 
adhesion molecule-1 during healing of ischemia-reperfusion-
induced gastric injury. Scand J Gastroenterol. 2000; 35(5):452-63. 
https://doi.org/10.1080/003655200750023697 PMid:10868446 
 
 
